Business of health: Onus is on drug companies to prove their products' worth.
AUSTRALIAN FINANCIAL REVIEW
Wednesday, 10 April 2002
Online Text: 690239
Pharmaceutical Benefits Advisory Committee
Cost effectiveness analysis
Track bills, Senators and Members.
Authorised Users | Login
Remote access for Parliamentary Computing Network account holders.
Parliament of Australia website survey